SYNLOGIC, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SYNLOGIC, INC. (SYBX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.63 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- SYNLOGIC, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 7.63M shares, a 2.06% decline year-over-year.
- SYNLOGIC, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 7.63M shares, a 1.16% decline year-over-year.
- SYNLOGIC, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 7.73M shares, a 3.30% decline year-over-year.
- SYNLOGIC, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 7.79M shares, a 0.28% decline year-over-year.
- SYNLOGIC, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 7.70M shares, a 2.70% decline from fiscal 2024.
- SYNLOGIC, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 7.91M shares, a 1.85% decline from fiscal 2023.
- SYNLOGIC, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 8.06M shares.
- SYNLOGIC, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2016 was 1.91M shares, a 79.84% decline from fiscal 2015.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 7.63M shares 10-Q · filed 2026-08-11 | 7.62M shares 10-Q · filed 2026-08-11 | ||||
| 2026-03-31 | 7.63M shares 10-Q · filed 2026-05-14 | |||||
| 2025-12-31 | 7.70M shares 10-K · filed 2026-03-12 | |||||
| 2025-09-30 | 7.73M shares 10-Q · filed 2025-11-13 | 7.73M shares 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | 7.79M shares 10-Q · filed 2026-08-11 | 7.79M shares 10-Q · filed 2026-08-11 | ||||
| 2025-03-31 | 7.72M shares 10-Q · filed 2026-05-14 | |||||
| 2024-12-31 | 7.91M shares 10-K · filed 2026-03-12 | |||||
| 2024-09-30 | 7.99M shares 10-Q · filed 2025-11-13 | 7.99M shares 10-Q · filed 2025-11-13 | ||||
| 2024-06-30 | 7.81M shares 10-Q · filed 2025-08-07 | 4.33M shares 10-Q · filed 2024-08-08 | 8.00M shares 10-Q · filed 2025-08-07 | 4.53M shares 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | 8.11M shares 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | 8.06M shares 10-K · filed 2025-03-06 | |||||
| 2023-09-30 | 695.73K shares 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | 735.17K shares 10-Q · filed 2024-08-08 | 735.17K shares 10-Q · filed 2024-08-08 | ||||
| 2017-06-30 | 1.59M shares 10-Q · filed 2017-08-04 | |||||
| 2017-03-31 | 1.61M shares 10-Q · filed 2017-05-09 | |||||
| 2016-12-31 | 1.91M shares 10-K · filed 2017-03-15 | |||||
| 2016-09-30 | 2.10M shares 10-Q · filed 2016-11-10 | |||||
| 2016-06-30 | 1.91M shares 10-Q · filed 2017-08-04 | |||||
| 2016-03-31 | 1.92M shares 10-Q · filed 2017-05-09 | |||||
| 2015-12-31 | 9.45M shares 10-K · filed 2017-03-15 | |||||
| 2015-09-30 | 11.69M shares 10-Q · filed 2015-11-13 | 11.69M shares 10-Q · filed 2016-11-10 | ||||
| 2015-06-30 | 10.98M shares 10-Q · filed 2016-08-15 | |||||
| 2015-03-31 | 10.03M shares 10-Q · filed 2016-05-12 | |||||
| 2014-12-31 | 6.10M shares 10-K · filed 2017-03-15 | |||||
| 2014-09-30 | 6.09M shares 10-Q · filed 2015-11-13 | 6.09M shares 10-Q · filed 2015-11-13 | ||||
| 2013-12-31 | 5.95M shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |